Clinical Trial Update: Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex [Phase 3]

View source ↗

Summary

This entry reports the long-term results of a Phase 3 trial of topical sirolimus for angiofibromas in patients with tuberous sclerosis complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiofibroma
• Tuberous Sclerosis

Drugs mentioned

• Sirolimus (topical) (sirolimus)

Snippet

Sponsor: Nobelpharma | Conditions: Tuberous Sclerosis, Angiofibroma | Phase 3 | Status: COMPLETED